Abstract
Ginkgo biloba extract has been therapeutically used for several decades to increase peripheral and cerebral blood flow as well as for the treatment of dementia. The extract contains multiple compounds such as flavonoids and terpenoids that are thought to contribute to its neuroprotective and vasotropic effects. In this study, we investigated the effect of prolonged administration of EGb 761, up to 10 weeks, on mammalian retina using Fourier transform infrared spectroscopy (FTIR). Two main groups were involved in this study: the normal group (n = 10); and EGb-administrated group (n = 50) that received—orally—a dose of 40 mg/kg/day EGb 761. The results demonstrated that EGb administration was associated with different beneficial effects on the retinal constituents especially the underlying amide I protein secondary structure components as well as the NH-OH region. It concluded that the optimum daily administration period of EGb (40 mg/kg) for ophthalmic applications that targeting the retina ranges from 5 to 8 weeks.
Similar content being viewed by others
References
Nishida, S., & Satoh, H. (2005). Age-related changes in the vasodilating actions of Ginkgo biloba extract and its main constituent, bilobalide, in rat aorta. Clinica Chimica Acta, 354, 141–146.
Vesper, J., & Hänsgen, K. D. (1994). Efficacy of Ginkgo biloba in 90 outpatients with cerebral insufficiency caused by old age; results of a placebo-controlled double-blind trial. Phytomedicine, 1, 9–16.
Kennedy, D. O., Scholey, A. B., & Wesnes, K. A. (2000). The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology, 151, 416–423.
Le Bars, P. L., Katz, M. M., Berman, N., Itil, T. M., Freedman, A. M., & Schatzberg, A. F. (1997). A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA, 278, 1327–1332.
Diamond, B. J., Shiflett, S. C., & Schoenberger, N. E. (2000). Ginkgo biloba extract: Mechanisms and clinical indications. Archives of Physical Medicine and Rehabilitation, 81, 668–678.
Akiba, S., Kawauchi, T., Oka, T., Hashizume, T., & Sato, T. (1998). Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation. Biochemistry and Molecular Biology International, 46, 1243–1248.
Maclennan, K. M., Darlington, C. L., & Smith, P. F. (2002). The CNS effects of Ginkgo biloba extracts and ginkgolide B. Progress in Neurobiology, 67, 235–257.
Chung, H. S., Harris, A., Kristinsson, J. K., Ciulla, T., Kagemann, C., & Ritch, R. (1999). Ginkgo biloba extract increases ocular blood flow velocity. Journal of Ocular Pharmacology and Therapeutics, 15, 233–240.
Oh, S. M., & Chung, K. H. (2006). Antiestrogenic activities of Ginkgo biloba extracts. Journal of Steroid Biochemistry and Molecular Biology, 100, 167–176.
Drieu, K. (1988). Preparation and definition of Ginkgo Biloba extract. In Funfgeld, E. W. (ed.) Rokan (Ginkgo Biloba): Recent results in pharmacology and clinic (pp. 32–36). Berlin: Springer Verlag.
Ginter, E., Bobek, P., Kubec, F., Vozár, J., & Urbanová, D. (1982). Vitamin C in the control of hypercholesterolemia in man. International Journal for Vitamin and Nutrition Research, 23, 137–152.
Maitra, I., Marcocci, L., Droy-Lefaix, M. T., & Packer, L. (1995). Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochemical Pharmacology, 49, 1649–1655.
Miller, A. L. (1996). Antioxidant flavonoids: Structure, function and clinical usage. Alternative Medicine Review, 1, 103–111.
Szabo, M. E., Droy-Lefaix, M. T., & Doly, M. (1997). Direct measurement of free radicals in ischemic/reperfused diabetic rat retina. Clinical Neuroscience, 4, 240–245.
Kim, S. Y., Kwak, J. S., Shin, J. P., & Lee, S. H. (1998). The protection of the retina from ischemic injury by the free radical scavenger EGb-761 and zinc in the cat retina. Ophthalmologica, 212, 268–274.
West, S., Vitale, S., Hallfrisch, J., Muñoz, B., Muller, D., Bressler, S., et al. (1994). Are antioxidants or supplements protective for age-related macular degeneration? Archives of Ophthalmology, 112, 222–227.
Dovbeshko, G. I., Gridina, N. Y., Kruglova, E. B., & Pashchuk, O. P. (2000). FTIR spectroscopy studies of nucleic acid damage. Talanta, 53, 233–246.
Severcan, F., Toyran, N., Kaptan, N., & Turan, B. (2000). Fourier transform infrared study of the effect of diabetes on rat liver and heart tissues in the C-H region. Talanta, 53, 55–59.
Barth, A. (2007). Infrared spectroscopy of proteins. Biochimica et Biophysica Acta, 1767, 1073–1101.
Yang, L., Xu, Y., Su, Y., Wu, J., Zhao, K., Wang, M., et al. (2007). Study on the variations of molecular structures of some biomolecules induced by free electron laser using FTIR spectroscopy. Nuclear Instruments and Methods in Physics Research Section B, 258, 362–368.
Pézolet, M., Bonenfant, S., Dousseau, F., & Popineau, Y. (1992). Conformation of wheat gluten proteins. Comparison between functional and solution state as determined by infrared spectroscopy. FEBS Letters, 299, 247–250.
Rose, G. D., Young, W. B., & Gierasch, L. M. (1983). Interior turns in globular proteins. Nature, 304, 654–657.
Orpiszewski, J., Schoromann, N., Kluve-Beckerman, M., Liepnieks, J. J., & Benson, M. D. (2000). Protein aging hypothesis of Alzheimer disease. FASEB Journal, 14, 1255–1263.
Fuller, A. A., Du, D., Liu, F., Davoren, J., Bhabha, G., Kroon, G., et al. (2009). Evaluating β-turn mimics as β-sheet fold nucleators. PNAS, 106, 11067–11072.
de Alba, E., Santoro, J., Rico, M., & Jiménez, M. A. (1999). De novo design of a monomeric three-stranded antiparallel beta-sheet. Protein Science, 8, 854–865.
Severcan, F., & Haris, P. I. (2003). Fourier transform infrared spectroscopy suggests unfolding of loop structures precedes complete unfolding of pig citrate synthase. Biopolymers, 57, 160–168.
DeFeudis, F. V., & Drieu, K. (2000). Ginkgo biloba extract (EGb 761) and CNS functions: Basic studies and clinical applications. Current Drug Targets, 1, 25–58.
Manacha, C., Moranda, C., Crespya, V., Demigneèa, C., Texierb, O., Reègeèratb, F., et al. (1998). Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Letters, 426, 331–336.
Biber, A., & Koch, E. (1999). Bioavailability of ginkgolides and bilobalide from extracts of Ginkgo biloba using GC/MS. Planta Medica, 65, 192–193.
DeFeudis, F. V. (1998). Ginkgo Biloba extract (EGb 761): From chemistry to the clinic. Wiesbaden, Germany: Ullstein-Mosby.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gamal, E.M., Aly, E.M., Mahmoud, S.S. et al. FTIR Assessment of the Effect of Ginkgo biloba Leave Extract (EGb 761) on Mammalian Retina. Cell Biochem Biophys 61, 169–177 (2011). https://doi.org/10.1007/s12013-011-9173-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-011-9173-9